Vir Biotechnology grants director stock and options
The awards use distinct vesting schedules: some vest in installments beginning October 27, 2027, while others vest in full on the earlier of that date or the next annual meeting.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Vir Biotechnology, Inc. director Suzanne Louise Topalian was granted 8,000 and 4,731 restricted stock units (RSUs), plus options covering 16,000 and 9,462 shares, on October 27, 2026. Both option awards have an $11.57 exercise price and expire October 26, 2036.
Insider Trade Summary
Grant/Award: 38,193 shares
Grant/Award
4 txns
Insider
Topalian Suzanne Louise
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F4 | 16,000 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) F5 | 9,462 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1, F2 | 8,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1, F3 | 4,731 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 25,462 contracts (Direct);
Common Stock — 12,731 shares (Direct)
Footnotes (5)
- F1. Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
- F2. 1/3 of the RSUs will vest on October 27, 2027, and the remaining RSUs will vest in two equal annual installments thereafter.
- F3. The RSUs will vest in full on the earlier of (i) October 27, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.
- F4. 1/3 of the shares subject to the stock option will vest and become exercisable on October 27, 2027, and the remaining shares will vest and become exercisable in 24 equal monthly installments thereafter.
- F5. The shares subject to the stock option vest and become exercisable in full on the earlier of (i) October 27, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.
Key Figures
RSUs: 8,000 shares
RSUs: 4,731 shares
Stock option: 16,000 underlying shares
+3 more
6 metrics
RSUs
8,000 shares
Granted October 27, 2026; vesting begins October 27, 2027
RSUs
4,731 shares
Granted October 27, 2026; vest in full on the earlier of October 27, 2027, or the next annual meeting
Stock option
16,000 underlying shares
Granted October 27, 2026
Stock option
9,462 underlying shares
Granted October 27, 2026
Option exercise price
$11.57 per share
Applies to both option awards
Option expiration
October 26, 2036
Applies to both option awards
Key Terms
restricted stock units (RSUs), Equity Incentive Plan, vest and become exercisable
3 terms
restricted stock units (RSUs) financial
"Acquisition of restricted stock units (RSUs)"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Equity Incentive Plan financial
"pursuant to the Issuer's Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
vest and become exercisable financial
"shares subject to the stock option will vest and become exercisable"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock awards did VIR director Suzanne Louise Topalian receive?
On October 27, 2026, Suzanne Louise Topalian received 8,000 and 4,731 RSUs and options covering 16,000 and 9,462 shares. Both option awards have an $11.57 exercise price and expire October 26, 2036.
When do Suzanne Louise Topalian's VIR stock awards vest?
The 8,000 RSUs vest one-third on October 27, 2027, with the remainder in two equal annual installments thereafter; the option covering 16,000 shares vests one-third that day, with the remainder in 24 equal monthly installments. The 4,731 RSUs and option covering 9,462 shares vest in full on the earlier of October 27, 2027, or the date of the issuer's next annual meeting of stockholders.
AI-generated analysis. How Rhea-AI works. Not financial advice.
